Skip to content

Difference in patellar tracking before and after Journey II BCS total knee arthroplasty, evaluated with 4D CT imaging.

Difference in patellar tracking before and after Journey II BCS total knee arthroplasty, evaluated with 4D CT imaging.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON24890
Enrollment
100
Registered
2021-09-15
Start date
2021-12-31
Completion date
Unknown
Last updated
2024-06-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients with primary osteoarthritis of the knee and overall varus or neutral alignment of the leg.

Interventions

Undergoing total knee arthroplasty with or without the addition of a kneecap.

Sponsors

Radboudumc
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: • Non-inflammatory knee osteoarthritis, which is confirmed by radiology. • Osteoarthritis is unilateral or bilateral with the contralateral knee functioning properly, not operated on in the last 6 months. • Set to receive a primary cemented total knee arthroplasty. • Aged between 50 and 80 years, inclusive, on the day of the operation. • In stable health (ASA-score = 3) and is free of or treated for cardiac, pulmonary, haematological, or other conditions that would pose excessive operative risk. • Patient has a correctable or <10° rigid (non-correctable) varus deformity of the knee. • Participants must be able to give informed consent. • Patient plans to be available for follow-up until two years post-operative. • Ability to walk for 2 minutes without walking aid

Exclusion criteria

Exclusion criteria: Exclusion: • Valgus deformity • BMI > 35. • Previous hip /knee/ankle replacement surgery in the last 12 months, or is planned to have a hip replacement in the next 6-12 months. • Patient has had major, non-arthroscopic surgery to the study knee, including HTO. • Patient has an active, local infection or systemic infection • Incomplete or insufficient tissue surrounding the knee. • Severe damage to the medial or collateral knee ligaments and popliteal tendon • Documented osteoporosis with patient in active medical treatment. • Patient has physical, emotional or neurological conditions that impacts gait or balance, or would compromise compliance with post-operative rehabilitation and follow-up. • Bone quality compromised by disease or infection which cannot provide adequate support and/or fixation to the prosthesis • Knee flexion 30 degrees extension deficit (active restraint to extension) • Patient does not have a proper functioning patella tendon on the affected side; measured as inability of active extension of the knee • Patient has rheumatoid arthritis, any auto-immune disorder, immunosuppressive disorder or a terminal illness.

Design outcomes

Primary

MeasureTime frame
Difference in patellar tracking between pre-operative and one year post-operative measured with 4D CT imaging.

Secondary

MeasureTime frame
Implant positioning: By using the CORI, we will collect implant position, perioperative ligament laxities, alignment and tibiofemoral kinematics. Patient Reported Outcome Measures (PROMs): The following PROMs will be collected; FJS, KOOS and Kujala knee score to assess the patient experienced outcomes in pain and movement before and after the TKA.

Contacts

Public ContactMiriam Boot

Radboudumc

Miriam.boot@radboudumc.nl+31 (24) 361 69 59

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)